Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark
Author:
Publisher
Springer Science and Business Media LLC
Subject
Epidemiology
Link
http://link.springer.com/content/pdf/10.1007/s10654-007-9106-5.pdf
Reference18 articles.
1. Disse B, Speck GA, Rominger KL, Witek TJ Jr, Hammer R (1999) Tiotropium (Spiriva): Mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 64:457–464
2. US Package insert: Tiotropium
3. Morganroth J, Golisch W, Kesten S (2004) Lack of cardiac signals in COPD patients receiving tiotropium as defined by electrocardiographic monitoring in placebo controlled trials J Chronic Obstruct Pulm Dis 1:181–190
4. Gross NJ (2006) Anticholinergic agents in asthma and COPD. Eur J Pharmacol 533(1–3):36–39
5. Kesten S, Jara M, Wentworth C, Lanes SF (2006) Pooled clinical trial analysis of tiotropium safety. Chest 130:1695–1703
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis;European Respiratory Journal;2022-09-22
2. Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists;International Journal of Chronic Obstructive Pulmonary Disease;2022-08
3. A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink;International Journal of Chronic Obstructive Pulmonary Disease;2021-05
4. No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: A Drug Utilization Study;Scientific Reports;2020-01-17
5. Interest of pharmacoepidemiology for the study of inhaled drugs;Therapies;2019-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3